Reversible phosphorylation, involving protein kinases and phosphatases (PP), is important in regulating oocyte meiosis. Okadaic acid (OA) inhibition of PP1 and/or PP2A stimulates oocyte germinal vesicle breakdown (GVB). In oocytes, PP1 is localized in the cytoplasm and nucleus, yet endogenous regulation of oocyte PP1 has not been investigated. The objectives of the study were to identify intra-oocyte mechanisms regulating PP1 during acquisition of OA-sensitive meiotic competence and meiotic resumption. Immunohistochemical studies revealed that GVB-incompetent oocytes contained equivalent cytoplasmic and nuclear PP1. Upon development of OA-sensitive meiotic competence, PP1 displayed differential intracellular localization with significantly greater nuclear staining with distinct nucleolar rimming compared with cytoplasmic staining. Germinal vesicle-intact oocytes contained neither nuclear inhibitor of PP1, nor PP1 cytoplasmic inhibitor-1 transcripts or proteins. Reverse transcription-PCR with PP1 cytoplasmic inhibitor-2 (I2) primers and oocyte RNA amplified a predicted 330-bp product with the identical sequence to mouse liver I2. Oocytes contained a heat-stable PP1 inhibitor with biochemical properties of I2. Phosphorylation of PP1 at Thr320 by cyclin dependent kinase-1 (CDK1) causes PP1 inactivation. Germinal vesicle-intact oocytes did not contain phospho-Thr320-PP1. Upon GVB, PP1 became phosphorylated at Thr320 and this phosphorylation did not occur if GVB was blocked with the CDK1 inhibitor, roscovitine (ROSC). Inhibition of oocyte GVB with ROSC was reversible and coincided with PP1 phosphorylation at Thr320. Increased oocyte staining of nuclear PP1 compared with cytoplasmic staining at a chronological stage when oocytes gain meiotic competence, and phosphorylation and inhibition of PP1 by CDK1 at or around GVB appear to be important mechanisms in regulating oocyte PP1 activity and meiosis. In addition, these studies provide further support for PP1 being the OA-sensitive PP important in the regulation of the acquisition of meiotic competence, nuclear events during meiotic arrest, and GVB.
Introduction
first described the process of spontaneous maturation of mammalian oocytes when they demonstrated that oocytes and/or oocyte -cumulus complexes could be removed from antral follicles and, under appropriate culture conditions, matured to metaphase II (MII). These oocytes are considered to display meiotic competence. However, oocytes from pre-antral follicles cultured under similar conditions do not mature, and thus exhibit meiotic incompetence. Acquisition of meiotic competence is correlated with oocyte size (Schultz & Wassarman 1977) , follicular morphology (Erickson & Sorenson 1974 ) and species-dependent prepubertal chronological age (Schultz & Wassarman 1977) . Germinal vesicle breakdown (GVB)-competent and -incompetent oocytes display divergence in overall protein synthesis (Schultz & Wassarman 1977) and expression of specific transcript and protein (Chesnel & Eppig 1995 , Harrouk & Clarke 1995 , Mitra & Schultz 1996 . Importantly, sensitivity to GVB stimulators, such as the protein phosphatase-1 (PP1) and the PP2A inhibitor, okadaic acid (OA) (Gavin et al. 1991 , Hampl & Eppig 1995 , can differentiate between these oocyte subclasses. Currently, the mechanisms controlling acquisition of meiotic competence are poorly understood.
Phosphorylation/dephosphorylation events are critical for resumption of meiosis (Bornslaeger et al. 1986) . Specific phosphorylation events during meiosis are regulated, in part, by M-phase promoting factor (MPF) and/or mitogen activated protein kinase (MAP kinase) (Hashimoto & Kishimoto 1988 , Naito & Toyoda 1991 , Chesnel & Eppig 1995 . Serine/threonine protein phosphatases (PPs) have also been implicated in regulating meiosis (Rime & Ozon 1990 , Gavin et al. 1991 , Schwartz & Schultz 1991 , Hampl & Eppig 1995 , Smith et al. 1998b . Okadaic acid stimulates GVB in starfish (Pondaven & Cohen 1987) , Xenopus , mouse (Alexandre et al. 1991 , Gavin et al. 1991 , Schwartz & Schultz 1991 , bovine (Levesque & Sirard 1995) and macaque (Smith et al. 1998b) oocytes. These reports using OA, either through microinjection or in culture, suggest that PP1 and/or PP2A are involved in the G2/M cell-cycle transition. Recently, it has been demonstrated that both PP1 and PP2A are present within mouse (Smith et al. 1998a) and monkey (Smith et al. 1998b) oocytes. In meioticallycompetent germinal vesicle (GV)-intact oocytes PP1 is predominantly nuclear and appears to be the PP that regulates GVB, whereas PP2A is predominantly cytoplasmic (Smith et al. 1998a ,b, Swain et al. 2003 .
Protein phosphatase-1, but not PP2A, is sensitive to the heat-and acid-stable cytoplasmic inhibitors 1 and 2 (I1 and I2) (Cohen 1989) . Inactivation of PP1 by I1 is dependent on I1 phosphorylation by protein kinase-A (PKA) (Nimmo & Cohen 1978) , whereas I2 does not require phosphorylation for PP1 inhibition (Nimmo & Cohen 1978) . Protein phosphatase-1 is activated by a reaction controlled by glycogen synthase kinase-3 (GSK-3) phosphorylation of I2 (Hemmings et al. 1982 , Resink et al. 1983 . Because PP1 has been detected in the nuclei of numerous cell types (Jessus et al. 1989 , Ohkura et al. 1989 , experiments have focused on identification of a nuclear PP1 inhibitor. Nuclear inhibitor of PP1 (NIPP-1) has been isolated, characterized and cloned from thymus and liver (Beullens et al. 1992 , Jagiello et al. 1995 , Van Eynde et al. 1995 . In addition, PP1 activity in somatic cells can be inhibited by phosphorylation at Thr320 (Van Eynde et al. 1995) . This phosphorylation and inactivation of PP1 is regulated by cyclin dependent kinase-1 (CDK1) (Dohadwala et al. 1994) , which oscillates during mitotic cell cycle progression (Kwon et al. 1997) . M-phase promoting factor (Mitra & Schultz 1996) and PP1 (Smith et al. 1998a,b) translocate into oocyte nuclei in accordance with acquisition of meiotic competence, and remain predominantly nuclear until GVB. Because MPF is composed of CDK1 and cyclin-B, it is possible that oocyte nuclear MPF regulates nuclear PP1 phosphorylation and activity, and that this mechanism may be important in regulating phosphorylation of nuclear proteins in association with GVB. Such an event has yet to be reported.
The objectives of the present study were to elucidate intra-oocyte mechanisms of PP1 regulation in relation to cellular events influenced by the PP1/PP2A inhibitor, OA. Experiments were conducted to determine differential intracellular localization of PP1 and to investigate the role of endogenous cytoplasmic and nuclear inhibitors of PP1 and MPF-regulated PP1 phosphorylation and inactivation during acquisition of OA-sensitive meiotic competence and resumption of meiosis.
Materials and Methods

Collection of mouse ovaries
Ovaries were obtained from CF-1 female mice on day 11, 15 or 17 (day 0 ¼ day of birth) without hormonal stimulation or from adults primed with 10 IU equine chorionic gonadotropin (eCG; Sigma Chemical Co., St Louis, MO, USA). Time points were selected in order to bracket a time when oocytes gain meiotic competence, as described by sensitivity to OA-induced GVB. For immunohistochemical studies, ovaries were fixed in 4% paraformaldehyde (prepared fresh daily), rinsed in PBS and embedded in paraffin.
Immunohistochemistry (IHC)
Fixed, paraffin-embedded ovaries were sectioned at 5-micron intervals, placed on superfrost-plus slides (Fisher Scientific, Itasca, IL, USA), deparaffinized, placed in 100 mM glycine buffer (pH 3.65) and microwaved for 10 min for antigen retrieval (Shi et al. 1995) . To reduce background signal, samples were placed in Tris-buffered saline (TBS; 50 mM Tris pH 7.6, 150 mM NaCl) containing 5.0% dimethyl sulfoxide and 0.2% Tween-20 for 10 min, rinsed in TBS and incubated for 10 min in TBS containing 0.3% BSA, 1 mg/ml sodium azide and 1.6% normal goat serum (Vector Laboratories, Burlingame, CA, USA). In addition, endogenous avidin and biotin were neutralized with an avidin/biotin blocking kit (Vector Laboratories). Slides were rinsed and incubated overnight with anti-PP1 a antibody diluted 1:250 at room temperature in a humidified chamber. Slides were then rinsed, washed (TBS þ 0.05% Tween-20) and incubated with the biotinylated secondary antibody for 30 min at room temperature. Following secondary antibody exposure, slides were quenched in 3.0% H 2 O 2 in 90% methanol for 30 min, then rinsed and incubated for 30 min in avidin-biotin conjugated to peroxidase (Vector Laboratories). After several rinses, sections were exposed to 0.025% 3,3 0 -diaminobenzidine (Dojindo Labs-Wako Chemical, Richmond, VA, USA), rinsed, counterstained with Mayer's hematoxylin (Sigma Chemical Co.), dehydrated by three changes of ethanol, then three changes of xylene, and mounted. Negative controls included (1) elimination of the primary antibody (not shown) and (2) non-immune rabbit serum in place of the primary antibody.
The ratios of PP1 a nuclear-to-cytoplasmic staining intensity in GVB-incompetent and -competent oocytes were determined with a Leica DMR microscope ( £ 1000; Leica Microsystems Inc., Bannockburn, IL, USA), using image acquisition with a SPOT-RT digital camera (Diagnostic Instruments Inc., Sterling Heights, MI, USA) and subjected to computerized densitometry (Scion Image, Scion Corp., Frederick, MD, USA). Briefly, oocyte micrographs had hematoxylin staining digitally removed prior to conversion to gray-scale (Adobe Photograph, Adobe System Inc., Mountain View, CA, USA). Regions of interest containing 80-90% of either cytoplasm or nucleus were used to calculate mean pixel intensity of PP1 a staining within the cytoplasm and nucleus. Differences in nuclearto-cytoplasmic staining intensity ratios of PP1 a in oocytes within ovaries isolated from 11-, 15-and 17-day-old mice were evaluated for statistical significance using Student's unpaired t-test. Differences were considered statistically significant at P , 0.05.
Oocyte collection and meiosis
Fully grown GVB-competent oocytes were collected from eCG-treated (10 IU) 19-to 23-day-old CF-1 mice utilizing a protocol approved by the University of Michigan Committee on the Use and Care of Animals. Oocytes were collected by puncturing antral follicles in HEPES-buffered human tubal fluid medium (H-HTF; Irvine Scientific, Santa Ana, CA, USA) with 0.3% polyvinylpyrrolidone (PVP; Sigma Chemical Co.). Oocytes used for Western blot analysis or RT-PCR were completely freed of attached cumulus cells via repeated mouth pipetting before freezing in liquid nitrogen and storage at 2 80 8C. Cumulus-enclosed meiotic-competent oocytes were cultured in HTF þ 0.3% BSA (control) or HTF containing 150 mM of the CDK1 inhibitor, roscovitine (ROSC; Tocris, Ballwin, MO, USA) without oil overlay for 2 h at 37 8C with 5% CO 2 . This dose of ROSC was chosen based on dose-titration experiments and it completely inhibits oocyte GVB in our studies. A subset of ROSC-treated oocytes was removed from culture after 2 h, washed extensively in H-HTF þ 0.3% PVP and placed into HTF þ 0.3% BSA for an additional 2 h. At the end of culture cumulus cells were removed, GVB was assessed with an inverted microscope with Hoffman optics at £ 400, and oocytes were frozen in liquid nitrogen and stored at 280 8C until used for Western blot analysis.
Oocyte RNA isolation and RT-PCR
Eighty to one hundred oocytes were thawed in 20 IU RNasin (Promega, Madison, WI, USA), pooled and lysed with 5 freeze/thaw cycles in liquid nitrogen. Total RNA was isolated as previously described (Heikinheimo et al. 1995 , Smith et al. 1998a . Complementary DNA was synthesized using the Superscript Preamplification System for First Strand cDNA Synthesis reagents and methodology (Gibco BRL, Gaithersburg, MD, USA). Oligo-dT was used to prime reverse transcription reactions. For I1, I2, and NIPP-1 PCR, sense and antisense primers were designed from areas with least homology between related cDNAs (i.e. I1 and I2) to amplify size-discernible products with distinct restriction endonuclease digestion sites (Table 1) . Each PCR was performed with five oocyte equivalents of cDNA, 20 pmoles of each primer, and a PCR cocktail (0.4 mM of each dNTP, 2.0 mM MgCl 2 , 10.0 mM Tris -HCl (pH 8.3), 50.0 mM KCl and 2 IU Taq DNA polymerase (Perkin-Elmer, Foster City, CA, USA)). In addition, control reactions were conducted consisting of (1) no template with primers and cocktail; (2) no primers with cDNA template and cocktail; (3) no template or primer with cocktail and (4) total RNA as template (equivalent to 5 oocytes) with primers and cocktail. Total RNA controls were only performed if amplification signals were previously identified in oocytes. Polymerase chain reactions entailed 1 cycle for 2 min at 94 8C; 35 cycles at 94 8C for 1 min, 55 8C (NIPP-1), 57 8C (I1) and 58 8C (I2) for 1 min, 72 8C for 1 min and 1 cycle at 72 8C for 2 min.
Polymerase chain reaction products were separated on 2.0% low melting agarose gels (Sigma Chemical Co.) and isolated as previously described (Smith et al. 1998a) . Portions of the amplified products were digested for 2 h with BamHI (I1), HindIII (I2) or BamHI (NIPP-1). Undigested and digested PCR products, as well as PCR controls, were separated using 8% polyacrylamide gel electrophoresis and visualized with ethidium bromide staining. Reverse transcription-PCR experiments were performed in triplicate with each primer set to ensure repeatability of results. In addition, purified PCR products were sequenced by cycle sequencing (ABI Prism, Perkin Elmer) followed with product analysis using an Applied Biosystems Model 373A DNA Sequencer. Sequences obtained were 
PP1 cytoplasmic inhibitor assay
In order to determine the presence of I1 and/or I2 at the protein level, human sperm, mouse brain and approximately 200 meiotic-incompetent and -competent oocytes were used to prepare heat-stable extracts as previously described . Pooled human sperm sonicates were prepared and used as the PP1 source in this assay . Boiled extracts (inhibitor source) and a PP1 source were incubated in duplicate for 10 min at 30 8C before a standard PP assay was performed using 32 P-phosphorylase-a as the PP substrate (Gibco BRL) . After incubation with 32 P-phosphorylase-a, reactions were terminated with the addition of ice-cold 20% trichloroacetic acid (TCA) on ice for 10 min; samples were centrifuged and supernatants were evaluated for 32 P release in response to the PP source with or without previous inhibitor source exposure. To identify the PP inhibitor (I1 or I2) present in mouse oocytes, heat stable sonicates were incubated in duplicate with 10 mm ATP (Sigma Chemical Co.) with or without 1 -2 mU PKA (Sigma Chemical Co.) for 10 min at 30 8C. Reactions were terminated in a 100 8C water bath for 10 min and cooled at 30 8C. The protein phosphatase source was added before the PP assay was conducted. Positive control reactions for the assay of specific inhibitors utilized boiled extracts prepared from mouse brain (I1 and I2) (Endo et al. 1996 , Kawai et al. 2001 and human sperm (I2) . Experiments were performed in duplicate.
Electrophoresis and Western blot analysis
Two hundred frozen cumulus cell-free fully grown GVintact and GVB oocytes were thawed in pre-warmed 2 £ SDS PAGE sample loading buffer (80 mM Tris-HCl (pH ¼ 6.8), 20% glycerol, 4% SDS, 4% b-mercaptoethanol, 0.04% bromophenol blue), vortexed and placed on ice for 15 min. Following sonication on ice, samples were denatured at 90 8C for 10 min and cooled on ice for 5 min. Total protein from two hundred mouse oocytes was added per lane and separated by one-dimensional SDS-PAGE (Laemmli 1970) . Approximately 5 mg of rat and mouse liver protein were loaded per lane as positive controls for detecting NIPP-1. HeLa cell lysate was used as a positive control for recognizing PP1 and phospho-Thr320-PP1. Gels were equilibrated and transferred to Hybond-P PVDF transfer membrane (Amersham Life Sciences, UK) by Semi-Dry Electrophoretic Transfer (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer's instructions. After blocking, blots were incubated with either anti-NIPP-1 antibody (diluted 1:5000; kindly provided by Dr Bollen), or anti-phospho-Thr320-PP1 (diluted 1:1000; Cell Signaling Technology Inc., Beverly, MA, USA) antibody in TBST (25 mM Tris pH 7.6, 125 mM NaCl, 0.1% Tween-20) plus 5% nonfat milk overnight at 4 8C with agitation. Blots were washed in TBST, incubated with anti-rabbit horseradish peroxidase-conjugated IgG (diluted 1:10 000) at room temperature for 1 h, washed again in TBST and developed with ECL Plus reagents (Amersham Life Sciences) according to the manufacturer's instructions. After phospho-Thr320-PP1 assessment, blots were stripped for 30 min at 50 8C in a water bath with agitation using a stripping buffer (62.5 mM Tris-HCl (pH 6.7), 100 mM b-mercaptoethanol and 2% SDS). Completely stripped blots were blocked in 5% nonfat milk in TBST for 1 h at room temperature, then incubated with anti-PP1 a antibody (diluted 1:1000; kindly provided by Dr Angus Nairn, Rockefeller University) overnight at 4 8C with agitation, and processed further as described above.
Results
PP1 localization and meiotic competence
Increased PP1 in the oocyte nucleus may act as a regulatory mechanism during acquisition of meiotic competence. To further investigate this role of PP1, experiments were performed to determine nuclear-to-cytoplasmic PP1 staining intensity with respect to a chronological age when oocytes gain OA-sensitive meiotic competence (Gavin et al. 1991 , Chesnel & Eppig 1995 . Ovaries from 11-dayold mice contained GV-incompetent oocytes with very little nuclear PP1 (Fig. 1A) . On day 11, oocytes contained in secondary/preantral follicles had a nuclear-to-cytoplasmic staining intensity ratio of 1.1^0.1 (arbitrary units, mean^S.E.; Fig. 1B) . At 15 and 17 days of age oocytes began to display intense nuclear PP1 staining in accordance with approximately 10% and 60% acquisition of meiotic competence, respectively (Fig. 1A) . On day 15, oocytes within follicles had a nuclear-to-cytoplasmic staining intensity ratio of 2.2^0.1 (arbitrary units, mean^S.E.; Fig. 1B) . On day 17, oocytes within follicles had a nuclear-to-cytoplasmic staining intensity ratio of 1.85^0.1 (arbitrary units, mean^S.E.; Fig. 1B ). Oocyte PP1 nuclear-to-cytoplasmic staining intensities on days 15 and 17 of age were significantly greater than on day 11 of age (P , 0.01).
Cytoplasmic PP1 inhibitors and mouse oocytes
Cytoplasmic PP1 activity can be regulated by inhibitor I1 and/or I2 (Ingebritsen et al. 1983) . Because PP1 has a cytoplasmic, as well as a nuclear location, experiments were performed to elucidate the presence/absence of I1 and/or I2 at the transcript and protein levels. Reverse transcription-polymerase chain reaction with mouse brain mRNA as a template amplified the predicted 310 bp product that contained a single BamHI digest site (Fig. 2A , lane F and G). Using the same primers, with fully grown GV-intact mouse oocyte mRNA as a template, RT-PCR experiments revealed that oocytes do not contain the I1 transcript ( Fig. 2A, lane E) . A similar approach was employed to assess oocytes for the presence of I2 mRNA. The fully grown mouse oocyte cDNA produced by RT-PCR with primers specific for I2 yielded a 330 bp product (Fig. 2B, lane F) that contained an anticipated HindIII digestion site (Fig. 2B, lane G) . Control PCR showed no reaction contamination. The sequenced mouse oocyte PCR product was identical to mouse liver I2.
Due to the absence of specific I1 or I2 antibodies, oocyte PP1 inhibitors were evaluated at the protein level for the ability to inhibit PP1 activity. In this assay, we utilized the heat-stable characteristics and differential sensitivity to PKA to identify I1 and I2 activity, and to discriminate between these inhibitors. Inhibitor 1 and I2 are distinguishable by their response to phosphorylation. Inhibitory activity of I1 is stimulated after phosphorylation by PKA, whereas I2 is PKA-independent. Incubation of boiled human sperm extract with the PP source resulted in a PP activity that was 27% of the control activity (PP source/no inhibitor source; Fig. 3 ). Co-incubation with PKA did not influence the inhibitor potential of boiled human sperm extracts. This is in agreement with our previous identification and characterization of I2 in human, monkey and bovine sperm . Incubation of boiled mouse brain extract with the PP source resulted in a PP activity that was 85% of the control activity. When PKA was co-incubated with boiled mouse brain extract a fourfold increase in the inhibitory potential of this extract was observed. These controls, human sperm containing I2 and mouse brain containing I1 and I2, performed as expected in validation of the assay's ability to identify heat-stable PP1 inhibitors and to differentiate between I1 and I2 activity. Both meiotic-incompetent and -competent mouse oocytes contain PP1 cytoplasmic inhibitor activity (Fig. 3) . In the absence of PKA, boiled meiotic-incompetent and -competent oocyte extracts resulted in PP activity that was 81% and 74% of control activity respectively. Co-incubation of either meiotic-incompetent or -competent extracts with PKA did not alter their inhibitory activity. Thus, the biological properties of the meiotic-incompetent and -competent mouse oocyte PP cytoplasmic inhibitor resemble those of I2.
NIPP-1 and mouse oocytes
When one considers the previously reported intense PP1 nuclear staining within fully grown GV-intact oocytes (Smith et al. 1998a,b) , questions arise regarding control of nuclear PP1 and the possible involvement of NIPP-1. Nuclear inhibitor of PP1 within oocytes was investigated at the transcript and protein levels. Primers for RT-PCR were designed based on the rat liver cDNA sequence. Amplification for the predicted 402 bp was detected using mouse liver cDNA as a positive control (Fig. 4A, lane F) . This RT-PCR product also contained the anticipated single BamHI site, that when cut yielded 331 and 71 bp products (Fig. 4A, lane G) . As assessed by RT-PCR, mouse meioticcompetent oocytes did not contain mRNA for NIPP-1 (Fig. 4A, lane E) . No amplification signals were detected in control reactions (Fig. 4A, lanes A-D) . Western blots were performed with an antibody that previously had been described to recognize calf thymus NIPP-1a and NIPP-1b at 18 and 16 kDa, respectively (Beullens et al. 1992) . In rat liver extracts, the major band recognized by the anti-NIPP-1 antibody corresponded to approximately 19 kDa. This immunogenically identified protein from rat liver matched the reported molecular mass of the purified 19 kDa PP1 inhibitory protein, which is believed to represent the rat liver homolog of calf thymus NIPP-1 (Zhao et al. 1996) . In addition, this antibody also identified a similar protein band from mouse liver. However, protein extracts from fully grown GV-intact oocytes were devoid of NIPP-1 (Fig. 4B) . Thus, fully grown mouse oocytes do not contain NIPP-1 transcript or protein.
PP1 phosphorylation by MPF at GVB
Inhibition of MPF's CDK1 subunit with ROSC blocks resumption of meiosis. Two hours after oocyte collection 88.4% of oocytes in control media (n ¼ 301) underwent GVB. Conversely, 0.6% of oocytes treated with 150 mM ROSC (n ¼ 190) underwent GVB (Fig. 5A ). This inhibitory 
Figure 3
Representative identification and characterization of heatstable cytoplasmic PP1 inhibitor activity in mouse GVB-competent and -incompetent oocytes. Boiled mouse brain and human sperm extracts were used as positive controls for I1 and I2 activities respectively. Boiled mouse GVB-competent and -incompetent oocyte extracts were tested for I1 and I2 activity. Protein phosphatase activity was measured for a known PP1 source and considered as 100% activity (control). Boiled extracts were added to the known PP1 source in the presence and absence of PKA with resulting decreases in PP activity (% of control) calculated for I1 and I2, respectively.
effect of ROSC was reversible since 86.7% (n ¼ 230) of ROSC-treated oocytes underwent GVB within 2 h following ROSC removal (Fig. 5A ). Protein phosphatase-1 and Thr320 phosphorylation of PP1 were assessed by Western blot analysis as represented in Fig. 5B . Protein phosphatase-1 was expressed at comparable levels in mouse oocytes at different developmental stages and under different treatments (Fig. 5B, top  panel) . Germinal vesicle-intact oocytes did not contain Thr320-phospho-PP1, while GVB oocytes did contain the phosphorylated protein. Blocking GVB with ROSC eliminated phosphorylation of PP1. If GV-intact oocytes were treated with ROSC for 2 h, washed extensively, and cultured for an additional 2 h, 87% of oocytes underwent GVB, and GVB oocytes contained phospho-Thr320-PP1 (Fig. 5B, bottom panel) .
Discussion
While the characterization, regulation and functional importance of numerous kinases are well defined in oocyte meiosis, knowledge of the specific role(s) of PPs and their regulation in oocytes is lacking. Results following treatment of oocytes with the PP1/PP2A inhibitors OA and calyculin-A (CL-A) suggest PP1 and/or PP2A are involved in GVB and progression to MII (Rime & Ozon 1990 , Gavin et al. 1991 , Schwartz & Schultz 1991 , Hampl & Eppig 1995 , Smith et al. 1998b ). Oocytes contain both PP1 and PP2A (Smith et al. 1998a,b) . In this report we have begun to elucidate the PP1 endogenous regulatory mechanisms within mouse oocytes. Localization of PP1 in the nuclei compared with the cytoplasm is a potential mechanism of regulating intracellular PP1 activity and/or function. When oocytes begin to acquire OA-sensitive meiotic competence the differential intracellular localization of PP1 in nuclei is strikingly evident. Determination of this PP1 localization demonstrates a twofold increase in nuclear/cytoplasmic staining intensity at a chronological period when oocytes acquire OA-sensitive meiotic competence (Schultz & Wassarman 1977 , Gavin et al. 1991 , Chesnel & Eppig 1995 . This differential localization of PP1 is independent of oocyte diameter and resident follicular stage. It is quite interesting that PP1 nuclear localization occurs at the same time as MPF is found to target to nuclei (Mitra & Schultz 1996) . One could hypothesize that this kinase/phosphatase pair may counteract phosphorylation of specific nuclear proteins involved with actual events of GVB. For example, hyperphosphorylation of nuclear lamins is an important step in initiating dissolution of the nuclear envelope (Peter et al. 1990) . During oocyte development after meiotic-competence acquisition, the nuclear envelope may be maintained intact by nuclear PP1 counteracting the phosphorylation by MPF at the lamina level. This theory correlates well with findings of OA stimulation of GVB in the presence of unchanged MPF activity (de Vantery et al. 1996) . Whether PP1 has the ability to regulate phosphorylation or oocyte nuclear lamins is currently under investigation. The presence of both PP1 and PP2A within mammalian oocyte cytoplasm raises questions about the functional importance of this intra-oocyte location and the methods of PP1/PP2A activity regulation. Of particular importance are differential methods of regulating oocyte cytoplasmic PP1 or PP2A. One such pathway involves the heat-and acid-stable inhibitors, I1 and I2. Currently no reports suggest the presence or absence of I1 in mammalian oocytes. Lack of I1 mRNA within fully grown oocytes, in conjunction with the inability to identify I1-like activity in germinal vesicle breakdown-incompetent and -competent oocytes indicate the absence of I1 in mouse oocytes. Presently, the only methods of assessing presence or absence of I1 protein are by chromatography purification and/or differential heat-stable PP1 inhibitor assays. Lack of an I1 specific antibody prevents immuno-detection. The heatstable PP1 inhibitor assay we have employed is commonly used to differentiate between I1 and I2 within cell and tissue extracts (Cohen 1978 , Pondaven & Cohen 1987 . Absence of I1 in mouse oocytes is in agreement with the report that starfish oocytes do not contain I1 (Pondaven & Cohen 1987) .
Starfish oocytes contain a heat-stable PP1 inhibitor with characteristics similar to I2 (Pondaven & Cohen 1987) . Here, we demonstrate that mouse oocytes also contain I2 as indicated by RT-PCR, cycle sequencing and inhibitor activity assay. As in starfish oocytes, the heat-stable inhibitor in mouse oocytes did not respond to preincubation with MgATP and PKA with respect to PP1 inhibitory activity, indicating that the heat-stable inhibitor is I2. Characteristics of the mouse oocyte heat-stable PP1 inhibitor are the same for both meiotic-incompetent and -competent oocytes. A recent report indicates that I2 translocates from cytoplasm to nuclei of HeLa and PC3 cells (Leach et al. 2002) . This raises the possibility that I2 not only controls cytoplasmic PP1 activity, possibly in association with condensing chromatin, but also controls nuclear PP1 activity in the regulation of nuclear lamin phosphorylation and GVB. Additionally, because I2 requires no activation to inhibit PP1 these data would suggest that oocyte PP1 is susceptible to I2 inhibition and that levels of I2, or the state of I2 phosphorylation, may be important determinants of overall oocyte PP1 activity. It is useful to remember that when I2 is phosphorylated by GSK-3, PP1 activity is restored. We have recently demonstrated that mouse oocytes also contain GSK-3 . Whether GSK-3 and/or I2 activity change with respect to meiotic progression remains to be investigated. In addition, the possible role of this oocyte-derived PP1/I2 system in fertilization and early embryo development warrants future attention.
During mitosis, PP1 phosphorylation at Thr320 is associated with inhibition of PP1 activity (Dohadwala et al. 1994) . In somatic cells PP1 becomes phosphorylated by CDK1 at the M2/G transition (Dohadwala et al. 1994 , Kwon et al. 1997 . Because inhibition of PP1 with exogenous means (such as OA administration) stimulates GVB, we surmised that an endogenous mechanism of inhibiting PP1 may be linked to GVB. At or around the time of GVB, PP1 becomes phosphorylated at Thr320. This PP1 phosphorylation is regulated by the CDK1 activity of MPF. Whether CDK1 directly phosphorylates the Thr320 residue and what proportion of oocyte PP1 becomes phosphorylated is not known at this time. This PP1 phosphorylation is not a time-dependent event in relation to removal of the oocyte from the follicle, but is dependent on MPF activity. These data also open up a new avenue of investigation involving MPF, PP1 and other nuclear proteins in the regulation of nuclear envelope integrity, breakdown, and reformation during oocyte meiosis.
In conclusion, differential intra-oocyte localization of PP1 to the nucleus when oocytes begin to gain meiotic competence suggests its importance in the regulation of meiotic competence acquisition, nuclear events during meiotic arrest, and GVB. In conjunction with GVB, PP1 becomes phosphorylated at Thr320, which is known to inhibit PP1 activity. This phosphorylation of oocyte PP1 is regulated by CDK1 activity of MPF. These studies have provided a link between MPF and PP1 at a developmental time-point when both these enzymes appear to be important in regulating oocyte GVB.
